文献速递肝胆胰外科

导管内乳头状黏液性肿瘤行远端胰腺切除术伴或不伴脾切除术后的结局:国际多中心队列研究

Outcomes after distal pancreatectomy with or without splenectomy for intraductal papillary mucinous neoplasm: international multicentre cohort study.
PubMed 文献 · Br J Surg · 2024-01-01

这项国际回顾性队列研究纳入7国14个高容量中心的700例因导管内乳头状黏液性肿瘤(IPMN)行远端胰腺切除术的患者,比较保脾远端胰腺切除术(SPDP,123例)与联合脾切除术的远端胰腺切除术(DPS,577例)。总体淋巴结转移率为6.7%,术前怀疑恶性的患者淋巴结转移率为17.2%,无怀疑者为4.3%。在无术前恶性怀疑的患者中,SPDP似乎肿瘤学安全,并与更短的住院时间和手术时间、更少的出血相关。

要点

  • 因IPMN行远端胰腺切除术的患者中,总体淋巴结转移率为6.7%(47例)。
  • 术前怀疑恶性者淋巴结转移率为17.2%,无怀疑者为4.3%,差异有统计学意义(P < 0.001)。
  • SPDP与DPS相比,手术时间更短(中位180 vs 226分钟)、出血更少(100 vs 336 ml)、住院更短(5 vs 8天)。

核心结论

  • 这项国际队列研究发现,因IPMN行远端胰腺切除术的患者中淋巴结转移率为6.7%;在无术前恶性怀疑的患者中,SPDP似乎肿瘤学安全,并与短期结局改善相关。

研究设计与样本

  • 国际回顾性队列研究,纳入7国14个高容量中心2005年至2019年连续因IPMN行远端胰腺切除术的患者,共700例,分为SPDP组(123例,17.6%)与DPS组(577例,82.4%)。

主要发现

  • 总体恶性率为29.6%(137例),总体淋巴结转移率为6.7%(47例)。
  • 术前怀疑恶性者淋巴结转移率为17.2%(134例中23例),无术前恶性怀疑者为4.3%(539例中23例),P < 0.001。
  • SPDP与DPS相比,手术时间中位180 vs 226分钟(P = 0.001),出血量100 vs 336 ml(P = 0.001),住院时间5 vs 8天(P < 0.001)。
  • 校正预后因素后,SPDP与DPS的总体生存无显著差异(HR 0.50,95% CI 0.22至1.18;P = 0.504)。

临床怎么用

  • 原文结论指出,在无术前恶性怀疑的IPMN患者中,SPDP似乎肿瘤学安全,并与短期结局改善相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: International guidelines on intraductal papillary mucinous neoplasm (IPMN) recommend a formal oncological resection including splenectomy when distal pancreatectomy is indicated. This study aimed to compare oncological and surgical outcomes after distal pancreatectomy with or without splenectomy in patients with presumed IPMN. METHODS: An international, retrospective cohort study was undertaken in 14 high-volume centres from 7 countries including consecutive patients after distal pancreatectomy for IPMN (2005-2019). Patients were divided into spleen-preserving distal pancreatectomy (SPDP) and distal pancreatectomy with splenectomy (DPS). The primary outcome was lymph node metastasis (LNM). Secondary outcomes were overall survival, duration of operation, blood loss, and secondary splenectomy. RESULTS: Overall, 700 patients were included after distal pancreatectomy for IPMN; 123 underwent SPDP (17.6%) and 577 DPS (82.4%). The rate of malignancy was 29.6% (137 patients) and the overall rate of LNM 6.7% (47 patients). Patients with preoperative suspicion of malignancy had a LNM rate of 17.2% (23 of 134) versus 4.3% (23 of 539) among patients without suspected malignancy (P < 0.001). Overall, SPDP was associated with a shorter operating time (median 180 versus 226 min; P = 0.001), less blood loss (100 versus 336 ml; P = 0.001), and shorter hospital stay (5 versus 8 days; P < 0.001). No significant difference in overall survival was observed between SPDP and DPS for IPMN after correction for prognostic factors (HR 0.50, 95% c.i. 0.22 to 1.18; P = 0.504). CONCLUSION: This international cohort study found LNM in 6.7% of patients undergoing distal pancreatectomy for IPMN. In patients without preoperative suspicion of malignancy, SPDP seemed oncologically safe and was associated with improved short-term outcomes compared with DPS.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Gorris M, van Bodegraven EA, Abu Hilal M, et al. Outcomes after distal pancreatectomy with or without splenectomy for intraductal papillary mucinous neoplasm: international multicentre cohort study. Br J Surg. 2024. PMID: 38195084. doi:10.1093/bjs/znad424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。